Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- AL Amyloidosis
- Monoclonal Gammopathy of Undetermined Significance
- Multiple Myeloma
- Plasma Cell Dyscrasias
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The investigators propose to contact and interact with all patients with plasma cell dyscrasias in the State of Ohio (and all patients diagnosed or treated at Ohio State Medical Center) for both surveillance and research purposes in order to develop interventions targeted to decrease their morbidity...
The investigators propose to contact and interact with all patients with plasma cell dyscrasias in the State of Ohio (and all patients diagnosed or treated at Ohio State Medical Center) for both surveillance and research purposes in order to develop interventions targeted to decrease their morbidity and mortality.
Tracking Information
- NCT #
- NCT01408225
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ashley Rosko, MD Ohio State University